Fatty Acid Breakdown Patterns Linked to Long COVID Risk
This study looked at how the body processes essential polyunsaturated fatty acids (PUFAs) after a SARS-CoV-2 infection, and whether differences in that processing relate to developing Long COVID. Researchers followed 106 people across two groups for up to a year, measuring specific fat-derived molecules in their blood using mass spectrometry.
They found that during the acute infection, people who went on to develop Long COVID showed higher activity of an enzyme pathway called 12-lipoxygenase, which breaks down PUFAs into various signaling molecules. In the months that followed, people with Long COVID also showed a pattern of disrupted or ‘uncoupled’ fat metabolism compared to those who recovered fully, with lipoxygenase activity continuing to shift abnormally over time.
The authors suggest these findings point to a breakdown in the body’s normal inflammation-resolution processes, which rely in part on fatty acid metabolites, as a possible contributor to why some people develop lasting symptoms after COVID-19.
What this means for you
This research doesn’t test any supplement or treatment, but it adds to growing evidence that how the body processes fats like omega-3s and omega-6s may play a role in recovering fully from infections. It’s an early, observational finding meant to guide future research rather than a basis for any specific action.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.